Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -219.15% is 406% below its 5-year average of -43.28%, near the low end of its 5-year range (-219.15%–52.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 52.06% below its 12-month average of -144.12%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -219.15%.
RETURN ON INVESTED CAPITAL (ROIC)
-219.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-144.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-64.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-43.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-73.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-52.06%
CURRENT VS 3Y AVG
-241.00%
CURRENT VS 5Y AVG
-406.37%
CURRENT VS 10Y AVG
-198.41%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.73%
median of 709 covered companies
CURRENT VS SECTOR MEDIAN
-549.71%
vs the sector median at left
Co-Diagnostics, Inc.
Market Cap
$6.69M
Return on Invested Capital (ROIC)
-219.15%
TTM Avg
-144.12%
3Y Avg
-64.27%
5Y Avg
-43.28%
Market Cap
$6.74M
Return on Invested Capital (ROIC)
-57.11%
TTM Avg
-311.64%
3Y Avg
-524.77%
5Y Avg
-524.77%
Market Cap
$6.80M
Return on Invested Capital (ROIC)
-90.17%
TTM Avg
-79.44%
3Y Avg
-64.42%
5Y Avg
-71.54%
Market Cap
$6.49M
Return on Invested Capital (ROIC)
-107.99%
TTM Avg
-407.39%
3Y Avg
-445.97%
5Y Avg
-342.27%
Market Cap
$6.43M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-251.59%
3Y Avg
-2172.61%
5Y Avg
-1769.42%
Market Cap
$6.54M
Return on Invested Capital (ROIC)
-117.93%
TTM Avg
-116.75%
3Y Avg
-95.39%
5Y Avg
-83.55%
Market Cap
$7.07M
Return on Invested Capital (ROIC)
-102.91%
TTM Avg
-91.30%
3Y Avg
-374.81%
5Y Avg
-315.39%
Market Cap
$7.08M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-383.35%
3Y Avg
-220.46%
5Y Avg
-246.83%
Market Cap
$6.16M
Return on Invested Capital (ROIC)
-209.05%
TTM Avg
-147.42%
3Y Avg
-107.09%
5Y Avg
-98.13%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Co-Diagnostics, Inc. (CODX) | $6.69M | -219.15% | -144.12% | -64.27% | -43.28% |
| Aclarion, Inc. (ACON)vs › | $6.74M | -57.11% | -311.64% | -524.77% | -524.77% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.80M | -90.17% | -79.44% | -64.42% | -71.54% |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.49M | -107.99% | -407.39% | -445.97% | -342.27% |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.43M | N/A | -251.59% | -2172.61% | -1769.42% |
| Biomerica, Inc. (BMRA)vs › | $6.54M | -117.93% | -116.75% | -95.39% | -83.55% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.07M | -102.91% | -91.30% | -374.81% | -315.39% |
| NeuroSense Therapeutics Ltd. (NRSN)vs › | $7.08M | N/A | -383.35% | -220.46% | -246.83% |
| Femasys Inc. (FEMY)vs › | $6.16M | -209.05% | -147.42% | -107.09% | -98.13% |
| KALA BIO, Inc. (KALA)vs › | $7.07M | -232.05% | -321.25% | -211.94% | -167.22% |
ROIC
-219.1%
ROE
-370.2%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -219.15% |
| 2026-03-31 | -176.73% |
| 2025-12-31 | -147.54% |
| 2025-09-30 | -86.56% |
| 2025-06-30 | -90.64% |
| 2025-03-31 | -77.10% |
| 2024-12-31 | -70.71% |
| 2024-09-30 | -60.07% |
| 2024-06-30 | -51.33% |
| 2024-03-31 | -52.84% |
| 2023-12-31 | -47.68% |
| 2023-09-30 | -55.03% |
| 2023-06-30 | -50.71% |
| 2023-03-31 | -41.23% |
| 2022-12-31 | -22.63% |
| 2022-09-30 | 6.15% |
| 2022-06-30 | 16.07% |
| 2022-03-31 | 23.87% |
| 2021-12-31 | 25.00% |
| 2021-09-30 | 41.92% |
| 2021-06-30 | 52.23% |
| 2021-03-31 | 66.46% |
| 2020-12-31 | 61.94% |
| 2020-09-30 | 45.50% |
| 2020-06-30 | 30.96% |
| 2020-03-31 | -29.66% |
| 2019-12-31 | -312.29% |
| 2019-09-30 | -173.90% |
| 2019-06-30 | -122.00% |
| 2019-03-31 | -105.38% |
| 2018-12-31 | -551.27% |
| 2018-09-30 | -241.94% |
| 2018-06-30 | -353.19% |
| 2018-03-31 | -173.55% |
| 2017-12-31 | -113.14% |
| 2017-09-30 | -65.39% |
| 2016-12-31 | -422.53% |
